Approximately 17% or 13 million dogs in the US alone are estimated to suffer from canine separation anxiety (CSA), which is anxiety or fear-related behavior that can occur when owners leave their dog alone. CSA can place immense emotional stress on the family. The signs associated with CSA (escaping to reach absent owner, whining and barking, panting and pacing, watching out the door or window obsessively until the owner returns, and house soiling) can diminish the quality of life for dog and owner alike. Owners with dogs suffering from CSA may relinquish them to shelters or even consider euthanasia in severe and extreme cases. If left untreated, CSA can have serious effects on the long-term health of the dog.
The good news is the problem is solvable.
Calmer Canine is a highly innovative, gentle, effective, safe and drug-free treatment system for canine separation anxiety. The Calmer Canine device delivers targeted pulsed electromagnetic field (tPEMF) signals to the area of the brain responsible for causing the symptoms of anxiety. It effectively returns the anxious brain to a more balanced emotional state with long-lasting effects. Early evidence suggests that Calmer Canine may also help dogs with other anxieties and fears, such as thunder phobia, noise sensitivity, travel anxiety, general anxiety, and situational anxiety. Calmer Canine has been proven to work alone without other treatments or training and is safe to use with other solutions for anxiety, such as medications.
The Calmer Canine treatment system includes a comfortable, easy to use vest that holds the device in the proper position over the dog’s head during treatments. Just two, fifteen-minute treatments daily for four to six weeks have been shown to significantly reduce signs of CSA, including barking, whining, howling, destruction, panting, pacing, watching out the door and windows obsessively, and house soiling, with lasting effects.
Calmer Canine delivers microcurrents of targeted pulsed electromagnetic field (tPEMF) signals to the area of the brain involved in controlling emotions such as anxiety.
Assisi is a global leader in the development of tPEMF technology with applications in veterinary medicine. Assisi has developed and conducted rigorous research on the Assisi Loop technology which is incorporated into our Loop, Loop Lounge and Loop Clinica products. This highly effective technology has been used to treat pain and inflammation in over 50,000 animals to date across the US and internationally.
Building off research conducted at Harvard University suggesting that tPEMF signals similar to that used in the Assisi Loop products were effective in treating people with mood disorders such as depression and anxiety, Assisi’s team of veterinarians, engineers and neurobiologists developed a new signal targeting the brain. This signal, delivered by Calmer Canine, is similar to that used in the Assisi Loop family of products, but it differs in certain key characteristics, e.g. the pulse frequency.
Similar to the Assisi Loop product line, the Calmer Canine signal is sensation-free, very safe, and very effective. However, instead of targeting pain and inflammation in joints and soft tissues, Calmer Canine’s signal was tuned to a different target - controlling anxiety in the brain. The tPEMF signals are low level and of sufficient strength to affect cellular metabolism and signaling but are below the threshold to cause an action potential. They are invisible and cause no perceptible sensation.
Research Highlights and Results
Assisi completed a pilot study testing the efficacy of Calmer Canine on dogs with separation anxiety. All participating dogs showed a marked reduction of canine separation anxiety symptoms within four weeks of starting treatment. Some dogs showed significant effects within an even shorter timeframe. Many of the dogs in the study retained or even continued to improve after treatments had been discontinued, suggesting long-lasting effects of Calmer Canine treatment.
Learn more about this research here
Have questions? Check out our FAQs here
Sign up for our newsletter